Save 20% on All Global Market Reports With Code ONLINE20 – Gain Insights Into Tariffs, Inflation, and Industry Trends
What Will Be the Forecast Market Size of the Global Personalized Medicine Market by 2029?
The personalized medicine market size has grown strongly in recent years. It will grow from $386.27 billion in 2024 to $422.9 billion in 2025 at a compound annual growth rate (CAGR) of 9.5%. The growth in the historic period can be attributed to rise of companion diagnostics, patient-centric healthcare, drug development paradigm shift, healthcare cost containment, increasing prevalence of chronic diseases.
The personalized medicine market size is expected to see rapid growth in the next few years. It will grow to $650.59 billion in 2029 at a compound annual growth rate (CAGR) of 11.4%. The growth in the forecast period can be attributed to continued genomic advancements, expansion of biomarker discovery, growing adoption of telemedicine, regulatory support and frameworks, collaboration and data sharing. Major trends in the forecast period include integration of artificial intelligence (AI), advancements in genomic sequencing, data integration and analytics, immunotherapy and targeted therapies, patient empowerment and informed decision-making, collaborations and partnerships.
Claim your free report sample now:
What Are the Leading Growth Factors in the Personalized Medicine Market?
The rising prevalence of rare diseases is expected to drive the growth of the personalized medicine market. This increase refers to the growing number of individuals diagnosed with conditions such as Klinefelter Syndrome, Aarskog Syndrome, and Abetalipoproteinemia. Personalized medicine offers tailored treatment options, addressing the unique needs of patients with rare diseases. For instance, in February 2024, according to the Genetic Alliance UK, a UK-based national charity supporting people affected by genetic, rare and undiagnosed conditions, in the UK, 3.5 million people are living with a rare condition, and 1 in 17 individuals will be affected by a rare condition at some point in their lifetime. Therefore, rising prevalence of rare diseases continues to grow, it is fueling the expansion of the personalized medicine market.
Which Segment Offers the Highest Growth Opportunities in the Personalized Medicine Market?
The personalized medicine market covered in this report is segmented –
1) By Product: Personalized Medicine Diagnostics, Personalized Medicine Therapeutics, Personalized Medical Care, Personalized Nutrition and Wellness
2) By Application: Oncology, Neurology, Blood Transfusion Safety, Diabetes, Autoimmune Diseases, Cardiology, Other Applications
3) By End-use: Hospitals, Diagnostic Centers, Research and Academic Institutes, Other End-Users
Subsegments:
1) By Personalized Medicine Diagnostics: Genetic Testing, Biomarker Testing, Companion Diagnostics, Molecular Imaging
2) By Personalized Medicine Therapeutics: Targeted Therapies, Gene Therapies, Monoclonal Antibodies, Cell and Gene Therapy Products
3) By Personalized Medical Care: Tailored Treatment Plans, Patient-Centric Care Models, Digital Health Solutions, Remote Patient Monitoring
4) By Personalized Nutrition And Wellness: Nutrigenomics, Customized Diet Plans, Supplement Personalization, Lifestyle Modification Programs
What Are the Notable Trends in the Personalized Medicine Market by Product, Application, and Region?
Technological advancements are a key trend gaining popularity in the personalized medicine market. Major companies operating in the personalized medicine market are adopting new technologies to sustain their position in the market. For instance, in April 2023, OM1, a US-based healthcare company that utilizes real-world data and artificial intelligence (AI) to assist healthcare providers, patented an AI-powered platform to accelerate personalized medicine. This technology employs large-scale data analysis to generate meaningful insights into diagnoses, progression, and treatment responses. Its significance lies in offering tailored healthcare inputs, enhancing informed decision-making for healthcare providers, and expediting clinical trials by identifying suitable candidates efficiently, contributing to the advancement of personalized medicine in the market.
Who Are the Leading Companies in the Personalized Medicine Industry by Revenue?
Major companies operating in the personalized medicine market include Bayer AG, Novartis AG, Thermo Fisher Scientific Inc., GlaxoSmithKline plc, AstraZeneca plc, Abbott Laboratories, Danaher Corporation, Eli Lilly and Company, Decode Genetics Inc., GE HealthCare Technologies Inc., Roche Diagnostics, Genentech Inc., Biogen Inc., Illumina Inc., Qiagen N.V., Exact Sciences Corporation, Myriad Genetics Inc., Verily Life Sciences LLC, Guardant Health Inc., Tempus Labs, Oxford Nanopore Technologies, Foundation Medicine Inc., NanoString Technologies Inc., Exagen Inc., Asuragen Inc., Personal Genome Diagnostics, Precision Biologics Inc., Strata Oncology, Genelex Corp, Invitae Corporation, Color Genomics, Helix OpCo LLC, 10x Genomics Inc., Agena Bioscience Inc., Natera Inc., Becton Dickinson and Company, PerkinElmer Inc., Sophia Genetics, Genomic Vision, Personalis Inc.
Get the full personalized medicine market report here:
What Are the Regional Opportunities for Investment in the Personalized Medicine Market?
North America was the largest region in the personalized medicine market in 2024. Asia-pacific is expected to be the fastest-growing region in the global personalized medicine market during the forecast period. The regions covered in the personalized medicine market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Contact Us:
The Business Research Company
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Comments
Post a Comment